Inhibikase Therapeutics (IKT) Stock Chart & Stock Price History $2.11 -0.15 (-6.64%) As of 04/25/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Inhibikase Therapeutics Stock Price Performance 5 Day Performance+11.64%1 Month Performance-11.72%3 Month Performance-24.91%6 Month Performance-12.81%Year-To-Date Performance-35.08%1 Year Performance+23.39% Receive IKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address IKT Stock Chart for Saturday, April, 26, 2025 IKT Chart by TradingView Inhibikase Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2025$2.26$2.11-6.64%$2.23$2.1093,404 shs$156.86 million04/24/2025$2.16$2.26+4.63%$2.26$2.11103,590 shs$168.01 million04/23/2025$1.96$2.16+10.20%$2.18$2.01112,002 shs$160.58 million04/22/2025$1.89$1.96+3.70%$1.97$1.79128,002 shs$145.71 million04/21/2025$1.90$1.89-0.26%$1.90$1.7962,382 shs$140.51 million04/18/2025$1.90$1.90$1.98$1.84162,822 shs$140.88 million04/17/2025$1.98$1.90-4.29%$1.98$1.84162,822 shs$140.88 million04/16/2025$1.90$1.98+4.21%$1.98$1.85123,459 shs$147.20 million04/15/2025$2.00$1.90-5.00%$2.10$1.89111,294 shs$141.25 million04/14/2025$2.07$2.00-3.38%$2.22$1.97190,252 shs$148.68 million Get the Latest News and Ratings for IKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/11/2025$1.86$2.07+11.29%$2.08$1.87105,774 shs$153.89 million04/10/2025$1.89$1.86-1.59%$1.98$1.7392,905 shs$138.28 million04/09/2025$1.66$1.89+13.86%$1.95$1.58212,330 shs$140.51 million04/09/2025$1.66$1.89+13.86%$1.95$1.58212,330 shs$140.51 million04/08/2025$1.68$1.66-1.19%$1.79$1.6184,277 shs$123.41 million04/08/2025$1.68$1.66-1.19%$1.79$1.6184,277 shs$123.41 million04/07/2025$1.84$1.68-8.70%$1.81$1.54352,589 shs$124.90 million04/04/2025$1.98$1.84-7.07%$1.93$1.77139,629 shs$136.79 million04/03/2025$2.18$1.98-9.17%$2.12$1.92104,880 shs$137.34 million04/02/2025$2.09$2.18+4.31%$2.27$2.00140,910 shs$151.21 million04/01/2025$2.19$2.09-4.57%$2.23$2.03236,268 shs$144.97 million03/31/2025$2.29$2.19-4.37%$2.33$2.14162,184 shs$151.90 million03/28/2025$2.37$2.29-3.38%$2.39$2.20104,788 shs$158.84 million03/27/2025$2.39$2.37-0.84%$2.42$2.33134,147 shs$164.39 million03/26/2025$2.37$2.39+0.84%$2.46$2.29155,765 shs$165.78 million03/25/2025$2.37$2.37$2.40$2.29136,911 shs$164.39 million Related Companies PHAR Stock Price Chart VALN Stock Price Chart ORGO Stock Price Chart CRMD Stock Price Chart OPT Stock Price Chart UPB Stock Price Chart BCYC Stock Price Chart IMTX Stock Price Chart PRTA Stock Price Chart KURA Stock Price Chart Receive IKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:IKT) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibikase Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibikase Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
